LAL, kinetic chromogenic, recombinant factor C: three ways to the same figure
The limit for a parenteral product is calculable from the dose and the body weight in two lines. Almost nobody in this trade performs the calculation.
Nikolaj Brandvold
Page 5 of 7 of this archive, newest first.
Archive — page 5
123 piecesThe question no chromatogram has ever answered
Purity, content, identity, sterility and endotoxin are five separate determinations. A single sheet of paper carrying one of them is not evidence about the other four.
The out-of-range flag is a statistical convention with a printer attached
A flag is a probability statement about a population. It is not a statement about the person holding the printout.
Independent analysis puts a Homopeptide tirzepatide lot at 99.3%, against 95.3% on the certificate
The result is unremarkable. What the report omits is not.
The supplement trade found this drug class quickly, and the citations did not improve
A survey of what the meta-analyses support, with the populations named.
Two sessions a week, and the evidence behind the prescription
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
Independent analysis puts a TFC tirzepatide lot at 97.7%, against 95.0% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
What Sweden customs does to a parcel it has decided to examine
A gel pack has a finite thermal budget, and once it is spent the payload equilibrates with whatever is outside the box. The only question is how long that takes.
Independent analysis puts a WXT tirzepatide lot at 96.4%, against 93.6% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Why a result on one vial says less than the trade needs it to
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
Quadrupole, time-of-flight, orbital trap: what each class can and cannot see
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
The certificate of analysis, line by line
The purity figure is the least informative line on a well-constructed certificate and the only line most buyers read.
The badge is about a sample. The listing is about a product.
Every step between the laboratory report and the product page removes information, and the badge is the last step.
Independent analysis puts a JEEP tirzepatide lot at 96.0%, against 92.6% on the certificate
The result is unremarkable. What the report omits is not.
PeptideMeter result on a Wuhan dulaglutide lot lands 1.8 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
What the sequence tells you about how a peptide will fail
Reversed-phase chromatography runs in an organic, acidic mobile phase that dissociates most non-covalent aggregates on the way to the detector.
VendorInvestigate result on a Tianjin tirzepatide lot lands 0.7 points below the supplier’s figure
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Two sessions a week, and the evidence behind the prescription
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
Independent analysis puts a SWB orforglipron lot at 97.7%, against 94.2% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Pore size, particle size, and why peptides need the wide pores
A shallow gradient resolves impurities that a steep one runs into the parent peak. Both methods are legitimate; only one of them can see the small stuff.